| Nov 7 |
Elanco Animal Health Reports Third Quarter 2024 Results
|
| Nov 6 |
Elanco Q3 2024 Earnings Preview
|
| Nov 4 |
Elanco Animal Health (ELAN) Q3 Earnings Preview: What You Should Know Beyond the Headline Estimates
|
| Oct 31 |
Elanco Animal Health Incorporated (ELAN) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release
|
| Oct 17 |
Will Elanco Animal Health (ELAN) Beat Estimates Again in Its Next Earnings Report?
|
| Oct 16 |
How Elanco Animal Health Incorporated (ELAN) is the Best Small-Cap Value Stock to Buy According to Hedge Funds
|
| Oct 10 |
Elanco Confirms Date and Conference Call for Third Quarter 2024 Financial Results Announcement
|
| Oct 7 |
Elanco gains FDA approval for Credelio Quattro parasiticide for dogs
|
| Oct 7 |
Elanco Receives FDA Approval for Credelio Quattro™ (lotilaner, moxidectin, praziquantel, and pyrantel chewable tablets), the Broadest(i) Canine Oral Parasiticide Protection in a Single Monthly Dose
|
| Sep 20 |
Elanco's Dermatology Treatment Secures FDA Approval For Itchy Dogs, Analyst Highlights Label Warnings And Efficacy
|
